Related Experiment Video
Updated: Mar 19, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Cost-effectiveness of point-of-care testing for dehydration in the pediatric ED
Rachel E Whitney1, Karen Santucci1, Allen Hsiao1
1Department of Pediatrics, Section of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06510.
Insights
Point-of-care (POC) electrolyte testing in pediatric emergency departments for acute gastroenteritis (AGE) significantly reduces costs for both payers and providers compared to traditional serum testing. This cost-effective approach aids in managing dehydration in children.
Area of Science:
- Pediatric Emergency Medicine
- Health Economics
- Clinical Diagnostics
Background:
- Acute gastroenteritis (AGE) and dehydration are common reasons for pediatric emergency department (PED) visits.
- Point-of-care (POC) testing is increasingly used for dehydration assessment, but its cost-effectiveness in the PED is not well-established.
- Traditional serum chemistry testing is the standard but may be less efficient.
Purpose of the Study:
- To conduct a cost-effectiveness analysis of POC electrolyte testing versus traditional serum chemistry testing for children with AGE in the PED.
- To evaluate cost savings from both payer and provider perspectives.
Main Methods:
- A cost-effectiveness analysis utilizing data from a randomized control trial involving children with AGE.
- A decision analysis model was developed to calculate cost savings.
- Parameters included testing costs, admission rates, admission costs, and length of stay.
- Sensitivity analyses were performed to ensure model stability.
Main Results:
- POC testing yielded a cost saving of $303.30 per patient for payers compared to traditional serum testing.
- POC testing provided mean savings of $36.32 per patient for providers ($8.29-$64.35).
- Sensitivity analyses confirmed the model's stability and consistent cost savings.
Conclusions:
- POC electrolyte testing in children with moderate dehydration due to AGE leads to significant cost savings for both payers and providers.
- This supports the adoption of POC testing as a cost-effective diagnostic strategy in the PED setting.
Objectives:
Acute gastroenteritis (AGE) and subsequent dehydration account for a large proportion of pediatric emergency department (PED) visits. Point-of-care (POC) testing has been used in conjunction with clinical assessment to determine the degree of dehydration. Despite the wide acceptance of POC testing, little formal cost-effective analysis of POC testing in the PED exists. We aim to examine the cost-effectiveness of using POC electrolyte testing vs traditional serum chemistry testing in the PED for children with AGE.
Methods:
This was a cost-effective analysis using data from a randomized control trial of children with AGE. A decision analysis model was constructed to calculate cost-savings from the point of view of the payer and the provider. We used parameters obtained from the trial, including cost of testing, admission rates, cost of admission, and length of stay. Sensitivity analyses were performed to evaluate the stability of our model.
Results:
Using the data set of 225 subjects, POC testing results in a cost savings of $303.30 per patient compared with traditional serum testing from the point of the view of the payer. From the point-of-view of the provider, POC testing results in consistent mean savings of $36.32 ($8.29-$64.35) per patient. Sensitivity analyses demonstrated the stability of the model and consistent savings.
Conclusions:
This decision analysis provides evidence that POC testing in children with gastroenteritis-related moderate dehydration results in significant cost savings from the points of view of payers and providers compared to traditional serum chemistry testing.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution

